Advocating distinct regulatory paths for embryos and embryo-like structures

Area of Science:

• Developmental Biology
• Bioethics
• Regulatory Science

Background:

• Human embryo-like structures (ELSs) are novel entities that model early human embryogenesis.
• ELSs currently exist in a regulatory gap, lacking specific legal frameworks for their governance.
• International consensus acknowledges the need to address this regulatory gap, though approaches vary.

Purpose of the Study:

• To analyze the regulatory status of ELSs, particularly those that may transition from modeling to replicating embryos.
• To distinguish between ELSs that model and those that replicate embryos.
• To propose regulatory frameworks for ELSs, considering UK and international perspectives.

Main Methods:

• Review of existing literature and bioethical reports, including the 2024 UK Nuffield Council on Bioethics report.
• Analysis of the distinction between ELSs as 'models' versus 'replicas' of embryos.
• Consideration of ethical and legal implications for regulating ELSs.

Main Results:

• ELSs currently model embryos but may evolve to replicate them, challenging existing regulatory definitions.
• The 2024 Nuffield Council report recommended separate regulation for stem cell-based embryo models.
• A clear distinction between modeling and replicating ELSs is crucial for future regulatory decisions.

Conclusions:

• A clear distinction between embryo models and replicas is necessary for appropriate regulation.
• Specific circumstances may require replicas to be regulated as embryos.
• Maintaining distinct regulatory pathways for embryos and ELSs is beneficial for advancing research and clinical applications while ensuring ethical oversight.